← Leaderboards
Chintan Dave
Rutgers Biomedical And Health Sciences
$2,727,689
Attributed
$2,727,689
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$2,727,689 · 2
By mechanism
R01$2,727,689 · 2
Top collaborators
No co-investigators on record.
Most similar at Rutgers Biomedical And Health Sciences
Same institution · by research overlap
- Christine Kim$37,058
Others in their field
Other Rising Stars on “Evidence Base”
- Rashada Alexander · American Association For The Advancement Of Science$22,676,040
- John Alam · Eip Pharma, Inc.$10,411,018
- Songthip T. Ounpraseuth · Univ Of Arkansas For Med Scis$10,363,762
- Sabrina Paganoni · Massachusetts General Hospital$9,819,674
- Suma Babu · Massachusetts General Hospital$9,819,674
- Jinsy Andrews · Columbia University Health Sciences$9,819,674
Research focus
Evidence BaseExclusionDatabasesEventClopidogrelAffectCaregiversClinical TrialsDrug PrescriptionsEffectivenessAgingAntiplatelet DrugsAreaAtherosclerosisAtrial FibrillationAdultAnticoagulantsBenefits And RisksCessation Of LifeClinically RelevantClinical DataCardiometabolismCardiovascular DiseasesGeriatrics
Grant awards (4)
Evaluating the role of multimorbidity in modulation medication effects in older adults$687,339
R01 · FY2025 · HL · contact PI
(R01) Strengthening the Evidence-Base to Support Medication Prescribing in Older Adults with Chronic Kidney Disease$671,986
R01 · FY2025 · DK · contact PI
Evaluating the role of multimorbidity in modulation medication effects in older adults$668,085
R01 · FY2024 · HL · contact PI
Evaluating the role of multimorbidity in modulation medication effects in older adults$700,279
R01 · FY2023 · HL · contact PI